Sugi Predict

Sugi Predict / Targets / EPDR1

EPDR1

Mammalian ependymin-related protein 1 · Q9UM22 · EPDR1 on Sugi Atlas →

0 patent compounds predicted against EPDR1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to EPDR1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation PHASE2/PHASE3UNKNOWN
Human Epilepsy Genetics--Neuronal Migration Disorders Study nanRECRUITING
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Genetics and Psychopathology in the 22q11 Deletion Syndrome nanUNKNOWN
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Molecular Diagnosis of Syndromic or Isolated Severe Intellectual Disability Using Whole Exome Sequencing : a Pilot Study nanCOMPLETED
CP-EDIT: Cerebral Palsy - Early Diagnosis and Intervention Trial nanRECRUITING
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Corpus Callosum Agenesis and Intellectual Disability nanCOMPLETED
Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes nanRECRUITING
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Search for Phenotype-modifying Genes in Patients With Intellectual Disabilities. nanNOT_YET_RECRUITING
Mapping Disease Pathways for Biliary Atresia nanRECRUITING
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing nanUNKNOWN
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia nanRECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Prospective Cohort Study of Neurogenetic Diseases nanRECRUITING
Improving Genetic Counseling for Patients With Spina Bifida Using Next Generation Sequencing nanCOMPLETED
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Neurogenetics Patient Registry nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a EPDR1 binder may also engage these)

ProteinNameSimilarity
A6QLI0 — 1.000 A6QLI0 →
Q5XII0 — 1.000 Q5XII0 →
Q99M71 — 1.000 Q99M71 →
Q9N0C7 — 1.000 Q9N0C7 →
P28770 — 0.993 P28770 →
P32188 — 0.992 P32188 →
P32187 — 0.990 P32187 →
P28771 — 0.990 P28771 →
Q90399 — 0.989 Q90399 →
P38528 — 0.988 P38528 →
P12958 — 0.988 P12958 →
P86729 — 0.988 P86729 →
Q91130 — 0.988 Q91130 →
P17561 — 0.987 P17561 →
P13506 — 0.987 P13506 →
P28772 — 0.987 P28772 →
Q6GPK2 — 0.986 Q6GPK2 →
P15262 — 0.984 P15262 →
Q66H42 — 0.984 Q66H42 →
Q4R540 — 0.983 Q4R540 →
P63056 — 0.983 P63056 →
P63057 — 0.983 P63057 →
Q5RB02 — 0.983 Q5RB02 →
Q5PQL7 — 0.983 Q5PQL7 →
IL4I1 L-amino-acid oxidase 0.983 landscape →
C0HKG5 — 0.983 C0HKG5 →
P48829 — 0.982 P48829 →
Q9Z0T6 — 0.982 Q9Z0T6 →
A2VDN0 — 0.982 A2VDN0 →
Q71SY6 — 0.982 Q71SY6 →